首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

到 2030 年南美洲和中美洲分子診斷市場預測 - 區域分析 - 按疾病領域、技術、產品和服務以及最終用戶

市場調查報告書

商品編碼

1452579

到 2030 年南美洲和中美洲分子診斷市場預測 - 區域分析 - 按疾病領域、技術、產品和服務以及最終用戶

South & Central America Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User

出版日期: 2024年01月05日 | 出版商:

The Insight Partners | 英文 102 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

南美洲和中美洲分子診斷市場預計將從2022年的12.2128億美元成長到2030年的26.7914億美元。預計2022年至2030年CAGR為10.3%。

分子診斷技術的進步推動了南美洲和中美洲分子診斷市場

分子診斷技術和平台正在應用於解剖學和臨床病理學的所有領域。與疾病相關的 DNA 或 RNA 序列，包括單核苷酸多態性、缺失、重排和插入，可在分子診斷測試中檢測到。 COVID-19出現後，分子診斷得到了進一步的改進。傳統上，CT掃描、血液學檢測和RT-PCR用於檢測。隨著 2020 年 COVID-19 病例的快速成長，對快速、精確的檢測平台的需求激增，以克服傳統檢測的缺點。電腦斷層掃描 (CT) 是一種成本密集型檢查，可能並非所有醫院都能提供，無法檢測無症狀患者的病毒感染和其他疾病。廣泛使用的RT-PCR也耗時且昂貴，無法檢測感染早期的低病毒量。因此，研究人員開發了檢測 SARS-CoV-2 的新方法，這種方法更快、更具成本效益。逆轉錄環介導等溫擴增 (RT-LAMP)、基於微陣列的檢測、基於適體的診斷、SHERLOCK、SHERLOCKv2、FET 生物感測器、基於細胞的電位診斷和分子印跡技術是新型分子診斷的一些例子為COVID-19 診斷所開發的技術。在過去幾年中，FDA 報告顯示分子檢測、抗原依賴性檢測和血清學檢測的進步已獲得批准。不同國家的科學界為管理 COVID-19 大流行和降低死亡率而共同努力，使整個分子工具和診斷領域受益，這可能會在未來為分子診斷市場創造重大機會。

南美洲和中美洲分子診斷市場概述

南美洲和中美洲的分子診斷市場分為阿根廷、巴西以及南美洲和中美洲的其他地區。該地區的市場成長歸因於人口老化、診斷市場的成長以及醫療器材行業主要參與者的不斷增加的舉措。此外，慢性病的流行需要有前景的診斷測試選擇，這有助於該地區的市場成長。

南美洲和中美洲分子診斷市場收入及 2030 年預測（百萬美元）

南美洲和中美洲分子診斷市場細分

南美洲和中美洲分子診斷市場分為疾病領域、技術、產品和服務、最終用戶和國家。

根據疾病領域，南美洲和中美洲分子診斷市場分為傳染病、腫瘤學、基因檢測、心臟病、免疫系統疾病等。 2022 年，傳染病細分市場在南美洲和中美洲分子診斷市場佔有率中佔據最大佔有率。

根據技術，南美洲和中美洲分子診斷市場分為聚合酶鏈反應（PCR）、原位雜合技術、等溫核酸擴增技術（INAAT）、DNA定序和下一代定序（NGS）、DNA微陣列和其他。聚合酶鏈反應 (PCR) 細分市場在 2022 年佔據南美洲和中美洲分子診斷市場最大佔有率。聚合酶鏈反應 (PCR) 進一步細分為 RT-PCR、qPCR、多重 PCR 等。

根據產品和服務，南美洲和中美洲分子診斷市場分為檢測和試劑盒、儀器、服務和軟體。 2022 年，檢測和試劑盒領域在南美洲和中美洲分子診斷市場佔有率中佔據最大佔有率。

根據最終用戶，南美洲和中美洲分子診斷市場分為診斷實驗室、醫院和診所、研究和學術機構等。 2022 年，診斷實驗室領域佔據南美洲和中美洲最大的分子診斷市場。

根據國家/地區，南美洲和中美洲分子診斷市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年，巴西將主導南美洲和中美洲分子診斷市場。

Abbott Laboratories、bioMerieux SA、Danaher、F. Hoffmann-La Roche Ltd、Illumina Inc、Novartis AG、Qiagen NV、Siemens Healthineers AG 和 Thermo Fisher Scientific Inc. 是南美洲和中美洲分子診斷領域的一些領先公司市場。

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

South & Central America Molecular Diagnostics Market Overview

The molecular diagnostics market in South & Central America is segmented into Argentina, Brazil, and the Rest of South & Central America. The market growth in the region is attributed to the aging population, growing diagnostics market, and the increasing initiatives by major players in the medical device industry. Furthermore, the prevalence of chronic diseases that demand promising diagnostic test options contributes to the market growth in the region.

South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Molecular Diagnostics Market Segmentation

The South & Central America molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the South & Central America molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest South & Central America molecular diagnostics market share in 2022.

Based on technology, the South & Central America molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest South & Central America molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the South & Central America molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest South & Central America molecular diagnostics market share in 2022.

Based on end users, the South & Central America molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest South & Central America molecular diagnostics market share in 2022.

Based on country, the South & Central America molecular diagnostics market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America molecular diagnostics market in 2022.

Abbott Laboratories, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd, Illumina Inc, Novartis AG, Qiagen NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the South & Central America molecular diagnostics market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Molecular Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 South & Central America PEST Analysis

5. South & Central America Molecular Diagnostics Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
- 5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
- 5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
- 5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
- 5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:

6. Molecular Diagnostics Market - South & Central America Market Analysis

6.1 South & Central America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

7.1 Overview
7.2 South & Central America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
- 7.3.1 Overview
- 7.3.2 Oncology: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
- 7.4.1 Overview
- 7.4.2 Infectious Disease: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
- 7.5.1 Overview
- 7.5.2 Genetic Testing: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
- 7.6.1 Overview
- 7.6.2 Cardiac Diseases: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
- 7.7.1 Overview
- 7.7.2 Immune System Disorders: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

8.1 Overview
8.2 South & Central America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
- 8.3.1 Overview
- 8.3.2 PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 RT-PCR
    - 8.3.2.1.1 Overview
- 8.3.3 RT-PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.3.1 qPCR
    - 8.3.3.1.1 Overview
- 8.3.4 qPCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.4.1 Multiplex PCR
    - 8.3.4.1.1 Overview
- 8.3.5 Multiplex PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.5.1 Others
    - 8.3.5.1.1 Overview
- 8.3.6 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Overview
- 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
- 8.5.1 Overview
- 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
- 8.6.1 Overview
- 8.6.2 DNA Microarrays: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
- 8.7.1 Overview
- 8.7.2 In-Situ Hybridization (ISH): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

9.1 Overview
9.2 South & Central America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
- 9.3.1 Overview
- 9.3.2 Assays and Kits: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
- 9.4.1 Overview
- 9.4.2 Instruments: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
- 9.5.1 Overview
- 9.5.2 Services and Software: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 South & Central America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals and Clinics: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
- 10.4.1 Overview
- 10.4.2 Diagnostics Laboratories: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
- 10.5.1 Overview
- 10.5.2 Research and Academic Institutes: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Molecular Diagnostics Market - Country Analysis

11.1 South & Central America Molecular Diagnostics Market, Revenue and Forecast to 2030
- 11.1.1 Overview
  - 11.1.1.1 South & Central America Molecular Diagnostics Market by Country
- 11.1.2 Brazil
  - 11.1.2.1 Overview
- 11.1.3 Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.4 Brazil: Molecular Diagnostics Market, by Disease Area
- 11.1.5 Brazil: Molecular Diagnostics Market, by Technology
  - 11.1.5.1 Brazil: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.6 Brazil: Molecular Diagnostics Market, by Product and Services
- 11.1.7 Brazil: Molecular Diagnostics Market, by End User
- 11.1.8 Argentina
  - 11.1.8.1 Overview
- 11.1.9 Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.10 Argentina: Molecular Diagnostics Market, by Disease Area
- 11.1.11 Argentina: Molecular Diagnostics Market, by Technology
  - 11.1.11.1 Argentina: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.12 Argentina: Molecular Diagnostics Market, by Product and Services
- 11.1.13 Argentina: Molecular Diagnostics Market, by End User
- 11.1.14 Rest of South & Central America
  - 11.1.14.1 Overview
- 11.1.15 Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
- 11.1.16 Rest of South & Central America Molecular Diagnostics Market, by Disease Area
- 11.1.17 Rest of South & Central America Molecular Diagnostics Market, by Technology
  - 11.1.17.1 Rest of South & Central America: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
- 11.1.18 Rest of South & Central America: Molecular Diagnostics Market, by Product and Services
- 11.1.19 Rest of South & Central America: Molecular Diagnostics Market, by End User

12. South & Central America Molecular Diagnostics Market Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. South & Central America Molecular Diagnostics Market, Key Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Qiagen NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 bioMerieux SA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Illumina Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Danaher
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Siemens Healthineers AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Novartis AG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. South & Central America Molecular Diagnostics Market Segmentation
Table 2. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
Table 3. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
Table 4. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 5. Brazil: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Product and Services
Table 6. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 7. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
Table 8. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
Table 9. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 10. Argentina: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Product and Services
Table 11. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 12. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
Table 13. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
Table 14. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
Table 15. Rest of South & Central America: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
Table 16. Rest of South & Central America: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

Figure 1. South & Central America - PEST Analysis
Figure 2. South & Central America Molecular Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 6. Oncology: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Infectious Disease: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Genetic Testing: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cardiac Diseases: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Immune System Disorders: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. South & Central America Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. RT-PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. qPCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Multiplex PCR: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. DNA microarrays: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. In-Situ Hybridization (ISH): South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 24. Assays and Kits: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Instruments: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Services and Software: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals and Clinics: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Research and Academic Institutes: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: South & Central America Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Molecular Diagnostics Market, By Country, 2022 (US$ Mn)
Figure 33. South & Central America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 34. Brazil: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Argentina: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Growth Strategies Done by the Companies in the Market (%)